Medi Assist Board Approves ₹49 Crore Share Buyback At ₹425

Muted Growth, Profit Surges PAT at Rs 21.6 Cr in Q2 FY27, +167.4% YoY. Revenue at Rs 242 Cr in Q2 FY27, +3.9% YoY. EBITDA at Rs 53.1 Cr, +26.4% YoY. EBITDA margin at 22.0% vs 18.1%. H1 FY27 EBITDA includes Rs 11.3 Cr non-cash gains (mutual fund sale, derivative fair value, FX) per CFS, ~236bps of revenue; adjusted EBITDA margin ~21.0% vs reported 23.3%. Board approved buyback of up to 11,59,199 shares at Rs 425 per share for Rs 49.3 Cr via tender offer, record date Nov 20 2026, promoters not participating. Auditors emphasised ED search at MAITPA Ranchi offices with no adjustment made; IRDAI clarifications pending on Paramount TPA business transfer/merger.